Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Neoplasms 10 Carcinoma, Non-Small-Cell Lung 7 Ovarian Neoplasms 6 Carcinoma, Transitional Cell 6 Squamous Cell Carcinoma of Head and Neck 5 Neoplasm Metastasis 5 Carcinoma, Renal Cell 5 Breast Neoplasms 4 Triple Negative Breast Neoplasms 3 Recurrence 3 Melanoma 3 Colorectal Neoplasms 3 Urinary Bladder Neoplasms 2 Sarcoma 2 Lymphoma, Follicular 2 Lymphoma 2 Central Nervous System Neoplasms 2 Uveal Melanoma 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Solid Tumors 1 Skin Neoplasms 1 Sezary Syndrome 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Peritoneal Neoplasms 1 Pancreatic Neoplasms 1 Mycosis Fungoides 1 Metastatic Urothelial Cell Cancer 1 Metastatic Solid Tumors 1

Interventions

Injections 18 Carboplatin 14 Docetaxel 11 pembrolizumab 8 durvalumab 7 Cisplatin 6 linifanib 5 Paclitaxel 5 Nivolumab 5 zimberelimab 4 talazoparib 4 olaparib 4 Panobinostat 4 Itraconazole 4 Bevacizumab 4 tremelimumab 3 sintilimab 3 depatuxizumab 3 atezolizumab 3 ST 1481 3 S 1 (combination) 3 Rifampin 3 Pemetrexed 3 Oxaliplatin 3 Fluorouracil 3 Everolimus 3 Drug Therapy 3 trifluridine tipiracil drug combination 2 trametinib 2 toripalimab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Advanced Solid Tumors × avelumab × Clear all

NCT02994953 2024-09-20

COMBO

EMD Serono

Phase 1 Terminated

52 enrolled 34 charts

Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡